Last updated on January 2019

CLEAR Sepsis Clinical Study


Brief description of study

To investigate the relationship between initial ClearSight derived hemodynamic parameters and outcomes (death, ongoing organ dysfunction or delayed ICU admission) in patients with acute infection and possible sepsis, with a focus on venous blood lactate (< 2.0, 2.0-3.9, and 4.0 mmol/dL) and hemodynamic subgroups, using ED patients presenting with minor infections or asthma/COPD exacerbations as controls (henceforth referred to as Sepsis Mimic Group).

Clinical Study Identifier: NCT03231956

Contact Investigators or Research Sites near you

Start Over

Detroit Receiving Hospital

Detroit, MI United States
  Connect »

Sinai-Grace Hospital

Detroit, MI United States
  Connect »

Ascension St. John Hospital

Detroit, MI United States
  Connect »

Beaumont Hospital, Royal Oak

Royal Oak, MI United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.